Structure-based classification of class A beta-lactamases, an update.

Area of Science:

• Biochemistry and Molecular Biology
• Microbiology and Infectious Diseases
• Genomics and Bioinformatics

Background:

• Beta-lactamase synthesis in Gram-negative bacilli is a primary mechanism of resistance to beta-lactam antibiotics.
• These enzymes are categorized into four molecular classes (A-D), with Class A serine enzymes being prevalent and susceptible to inhibitors.
• Advances in genomic approaches and sequencing technology have generated vast amounts of data on these enzymes.

Purpose of the Study:

• To develop a structure-based classification for Class A beta-lactamases.
• To identify conserved motifs and amino acid residues critical for catalytic mechanisms and substrate binding.
• To analyze the diversity of Class A beta-lactamase primary structures for phylogenetic classification.

Main Methods:

• Utilized genomic data and automatic sequencer technology to analyze a large dataset of beta-lactamase sequences.
• Employed a structure-based approach, focusing on conserved motifs (e.g., S70XXK, S130DN, K234TG) and specific amino acid residues.
• Validated the classification on 700 amino acid sequences, including 132 representative types and probable enzyme sequences from environmental bacteria.

Main Results:

• A structure-based classification was established for Class A beta-lactamases, incorporating catalytic and substrate-binding motifs.
• Two subclasses (A1, A2) and six major clusters (e.g., LSBL, WSBL) were identified based on conserved motifs and specific residues.
• Specific motifs and residues, including a probable disulfide bridge (C77-C123), were highlighted for subclasses and the LSBL group.

Conclusions:

• The study provides a refined, structure-based and phylogenetic classification of Class A beta-lactamases.
• This classification highlights the significant diversity within Class A beta-lactamases, based on primary structure.
• Understanding this diversity is crucial for tracking the evolution of antibiotic resistance and developing new therapeutic strategies.